13
Total investments
4
Early stage
0
Mid stage
1
Late stage
16y
Years active
Portfolio
7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2024
About Immedica Pharma
Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products.
Welcome to the Immedica social media channels
The Immedica social channels are set up to share news, updates, and company happenings with all visitors. Please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy.
Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly.
Examples of reasons for having a comment removed from a post on our social media might be:
- References a side effect or complaint
- Reporting of an adverse event, side effect or reaction from an Immedica product (that information should be reported directly to Immedica Drug Safety or to your physician.)
- A reference to a product or treatment
We work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice - your doctor or health care provider is the person to ask.
If you have a product enquiry, please email the Immedica medical department.
- Abusive language
We welcome your feedback, provided that you share your view in a way that is respectful to our community, meaning not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products
Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.
Board Member
Jun 2023
Biotage is a global partner in drug discovery, development, and analytical testing. With expertise in separation and purification technologies and a focus on intelligent workflow solutions, we help advance and protect human health.
D
Board Member
Dec 2021
Dawn Biopharma is a platform controlled by the KKR Healthcare Strategic Growth Fund II, established to own a diverse portfolio of companies committed to the development of innovative medicines and therapies. Dawn Biopharma aims to provide flexible capital to innovators and thought leaders across the life sciences ecosystem with a shared vision of delivering life-changing medicines to patients in need.
Board Member
Nov 2019
Gamma Biosciences is a life sciences tools platform created by KKR. Gamma’s mission is to build a leading player in next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses with outstanding technology and accelerating their growth.
Board Member
Mar 2016
We are a global leader in life science tools, partnering with customers to find solutions that diagnose, treat, feed and protect our growing population. Working collaboratively with our partners in the scientific community, our products and services help to solve some of the most complex challenges facing society and the planet.
Together we respond to global pandemics, pioneer innovative precision medicine, and improve the safety of our food, medicines and environment.
Angel Investor
Sep 2015
MyTutor is the UK’s leading online platform for one-to-one learning, and we're on a mission to improve the educational outcomes of thousands of young people. We’re building a future where access to high quality learning is stress-free for those who can afford it, and funded for those who can't.
One-to-one tuition is one of the most powerful ways to improve pupils’ grades, confidence and life chances. Yet it remains out of reach for many. Our handpicked community of tutors work online with students from all walks of life, raising results on average by one whole grade. Since the Covid-19 and all the disruption to education, we've worked with the government to provide safe and reliable tuition to more students than ever. We're proud to have worked with over 650 schools across the UK, and our tutors have given over a million lessons.
Since the pandemic, we've scaled up and kept a working environment that encourages collaboration and support. We always prioritise our team's development and wellbeing, remotely right now, and in an office again in the future. You can find your zen in team Yoga on Mondays, sweat it out at our Product Manager Jess's Bootcamp on Fridays (not for the faint-hearted) or get creative at Drink & Draw from our Content Manager Mariota. We have regular company socials and there are chances every week to sit down with someone for a cuppa and a chat. When it's legal, we're excited to get back to in-person socials too (landscape drawing in the park, anyone?).
Investor
Jun 2010
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
A trusted, global innovator in retail pharmacy with more than 12,500 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
WBA employs approximately 330,000 people and has a presence in eight countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.
The company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to being an inclusive workplace. In fiscal 2023, the Company received a score of 100 from the Human Rights Campaign’s Corporate Equality Index, scored 100 percent on the Disability Equality Index for disability inclusion and was named Disability:IN’s 2023 Employer of the Year. In addition, WBA has been recognized for its commitment to operating sustainably as the company is an index component of the Dow Jones Sustainability Indices (DJSI).
Experience · 17 entries
All (17)
Investments (13)
Founder (2)
Board (11)
2024
Board Member
Sep 2024
About Immedica Pharma
Immedica is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products.
Welcome to the Immedica social media channels
The Immedica social channels are set up to share news, updates, and company happenings with all visitors. Please note that postings by other visitors do not necessarily reflect the opinion of Immedica or confirm their accuracy.
Immedica will routinely monitor comments and Immedica reserves the right to remove any posts that do not comply with our guidelines and to block anyone who violates them repeatedly.
Examples of reasons for having a comment removed from a post on our social media might be:
- References a side effect or complaint
- Reporting of an adverse event, side effect or reaction from an Immedica product (that information should be reported directly to Immedica Drug Safety or to your physician.)
- A reference to a product or treatment
We work in a highly regulated industry that does not allow us to engage with the public in discussions about products – ours or other companies – or treatment options. We never provide healthcare advice - your doctor or health care provider is the person to ask.
If you have a product enquiry, please email the Immedica medical department.
- Abusive language
We welcome your feedback, provided that you share your view in a way that is respectful to our community, meaning not inappropriate, off-topic, harassing, spamming in nature, or promoting/soliciting third-party sites, initiatives, or products
Social media platforms may occasionally be unavailable, and we accept no responsibility for lack of service due to social media platform downtime.
2023
Board Member
Oct 2023
Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products.
As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.
We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.
Board Member
Jun 2023
Biotage is a global partner in drug discovery, development, and analytical testing. With expertise in separation and purification technologies and a focus on intelligent workflow solutions, we help advance and protect human health.
Board Member
Jan 2023
Clinisupplies is a UK based medical devices organisation, specialising in the manufacturing and marketing of products for primary and secondary healthcare.
2022
A
Board Member
Jul 2022
Alliance Pharma is a Contract Research Organization specializing in Drug Metabolism and Pharmacokinetic (DMPK) studies and offers bioanalytical services for both small and large molecules. The company’s services provide efficient and unproblematic guidance and support throughout the client’s drug development process from discovery efforts to pre-clinical and clinical investigations to market launch. Clients are provided with continuous access to personnel and data, thereby solidifying collaborative efforts in the development of life-changing products while assuring scientific, regulatory and data integrity.
Since the company’s inception in 2008, Alliance Pharma has earned itself a reputation among pharmaceutical and biotechnology companies for producing uncompromised data in the most efficient and cost-saving manner. For more information on Alliance Pharma, please visit: www. alliancepharmaco.com.
Show all 17 entries ↓
Investment activity
2010–2024 · 13 investments
Recent (last 2 years)Earlier
